439.98USD-0.54%Mkt Cap: 238.75B $P/E: 27.44Today
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthriti…
Industry Peers
Drug Manufacturers - General$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$375.50BUSDP/E 122.7
$341.92BUSDP/E 24.5
$279.13BUSDP/E 22.3
$274.07BUSDP/E 23.6
$240.45BUSDP/E 24.5
$231.49BUSDP/E 24.5
$190.75BUSDP/E 11.3
$183.02BUSD
$160.96BUSDP/E 37.2
$138.11BUSDP/E 14.9
$101.30BUSDP/E 24.0
$98.67BUSDP/E 16.3
$51.91BUSD
$32.74BUSDP/E 39.4
MRV
Marvell Technology, Inc.$26.57BUSDP/E 10.1
$12.10BUSDP/E 18.9
$12.07BUSDP/E 18.9
Key Statistics
Company
Market Cap238.75B $
Enterprise Value277.80B $
Revenue (TTM)38.09B $
Gross Profit24.71B $
Net Income (TTM)7.71B $
Revenue/Share70.68 USD
Last Price439.98 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees31.5K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS0311621009
Valuation
P/E (Trailing)27.44
P/E (Forward)17.78
PEG2.32
EV/EBITDA16.09
EV/Revenue7.29
P/S6.16
P/B20.06
EPS (TTM)15.79
EPS (Forward)24.40
52W Range
269.7798% of range443.19
52W High443.19 USD
52W Low269.77 USD
Profitability
Gross Margin67.25%
Oper. Margin35.55%
EBITDA Margin45.33%
Profit Margin20.98%
ROE89.06%
ROA8.51%
Growth
Revenue Growth9.50%
Earnings Growth64.90%
Cash Flow & Leverage
Operating CF9.96B $
CapEx (TTM)1.86B $
FCF Margin22.69%
FCF Yield3.62%
Net Debt43.31B $
Net Debt/EBITDA2.51
Balance Sheet
Debt/Equity6.31
Current Ratio1.37
Quick Ratio0.95
Book Value/Sh21.62 USD
Cash/Share25.88 USD
Dividends
Fwd Div Rate10.08 USD
Trail. Div Rate9.800 USD
Div. Yield2.28%
5Y Avg Yield3.07%
Payout Ratio60.87%
Ex-Div DateAug 21, 2026
Pay DateSep 11, 2026
Splits
Last Split2:1
Split DateNov 22, 1999
Analyst Consensus
Rating2.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)388.48 USD
Upside (mean)-11.7%
Target Range230.00 USD – 457.00 USD
$230.00-11.7% to mean$457.00
# Analysts29
Ownership
Shares Out.539.71M
Float539.16M
Insiders0.22%
Institutions85.12%
Short Interest
Short Ratio5.7d
Short % Float2.46%
Short % Out.2.45%
Shares Short13.28M
Short (prev mo.)12.87M
Technical
SMA 50376.93 (+16.7%)
SMA 200352.12 (+25.0%)
Beta0.41
S&P 52W Chg18.16%
Avg Vol (30d)2.21M
Avg Vol (10d)2.36M
Technical Indicators
RSI (14)79.4
MACD16.2657
MACD Signal13.6967
MACD Hist.+2.5690
BB Upper439.66 USD
BB Middle398.92 USD
BB Lower358.18 USD
BB Width20.43%
ATR (14)11.54 USD
Vol Ratio (20d)1.07x